What is Bronchoscope?

North America is expected to dominate the Overall Bronchoscopes Market

Among all the regions, North America is expected to account for the largest share in the global Bronchoscopes market. Factors such as rising prevalence of chronic obstructive pulmonary disease, increasing prevalence of various cancers including lung cancers, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bronchoscopes Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the bronchoscopes market growth in this region. 

As per the data provided by the Centers for Disease Control and Prevention, as of 2021, approximately 16 million people in the United States suffer from the chronic obstructive pulmonary disease (COPD) and variations associated with it such as chronic bronchitis and emphysema. Additionally, according to the data provided by the American Lung Association, in 2018, 156,045 people succumbed to COPD, making it the fourth overall leading cause of death behind heart disease, cancer, and accidents and unintentional injuries in the United States.

Get detailed information @ Bronchoscope Market Insights

COPD and its exacerbations result in airflow limitation, hyperinflation and reduced gas exchange which are often treated with devices such as endobronchial valves (EBV), endobronchial stents, and endobronchial coils (EBC) that are placed using bronchoscopes to open up the restricted airway. Therefore, the rising prevalence of COPD in the country would result in the rising demand for treatments that make use of bronchoscopes, which in turn would provide a conducive growth environment for the United States bronchoscopes market as well as the North American region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for bronchoscopes. For instance, in June 2021, Ambu Inc. received the product approval from the US Food and Drug Administration for their single-use bronchoscope and sample collection system. The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end users which in turn drives the product demand in the market. Therefore, the interplay of various factors such as the presence of large patient population, encouraging reimbursement policies as well as new product launches in the region are expected to boost the North America bronchoscopes market during the forecast period.

Bronchoscopes Market Companies

Some of the key market players operating in the bronchoscopes market includes Boston Scientific Corporation, Ambu Inc, Olympus, Richard Wolf GmbH, Karl Storz, FUJIFILM Corporation, PENTAX Medical (HOYA Corporation), Teleflex Incorporated, Innovex Medical Co., Ltd, Zhuhai Seesheen Medical Technology Co.,Ltd, EMOS Technology GmbH, Optomic., Clarus Medical LLC, The Surgical Company., Hunan Vathin Medical Instrument Co., Ltd., Aohua Endoscopy Co., Ltd, Verathon, Inc., Lymol Medical, Novatech SA, NeoScope Inc and others.